No Data
Tevogen Bio to Host Panel Discussions "AI In Biopharma: Next Frontier of Medical Innovation" and "Pioneering the Economics of Health: Balancing Access and Outcomes" During J.P. Morgan Healthcare Conference
What's Next for Biopharma? Tevogen's (TVGN) AI Breakthrough at the J.P. Morgan Conference
Express News | Tevogen Bio Expands IP Portfolio With Predictive AI Patent Filing To Advance T Cell Therapies And Accelerate AI Integration, Strengthening Position As An Industry Leader In Innovation And Accessibility
Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference
Express News | Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
